Development of a Non‐Coding‐RNA‐based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC

The objective of this study is to improve the overall prognosis of patients with hepatocellular carcinoma (HCC); therefore, new therapeutic methods that can be used in vivo are urgently needed. In this study, the relationship between the quantities of microRNA (miR)‐125b‐5p in clinical specimens and...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ruomi, Wu, Zhiqiang, Wang, Jing, Li, Qingling, Shen, Shunli, Wang, Weiwei, Zhou, Luyao, Wang, Wei, Cao, Zhong, Guo, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498119/
https://www.ncbi.nlm.nih.gov/pubmed/31065520
http://dx.doi.org/10.1002/advs.201801885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498119/
https://www.ncbi.nlm.nih.gov/pubmed/31065520
http://dx.doi.org/10.1002/advs.201801885

Ejemplares similares